iURO Oncology

iURO Oncology is the must-have app for all uro-oncology healthcare professionals and students. The narrated simulation videos make it easy to understand and explain the different pathologies and therapies. It can be used by doctors and nurses to enhance communication with their patients. Medical students can use iURO apps to increase their knowledge and understanding of various urological and oncological topics.

iURO Oncology can also be used by patients directly, to familiarize themselves with the different aspects of their oncological condition and the treatment options available.

Features include:

•Narrated simulation videos to explain prostate cancer, kidney cancer, bladder cancer and testicular cancer

•Narrated simulation videos to explain different treatment options

•Draw on picture, offering the opportunity to draw on and make personalized notes on a 3D image

•Send this customized 3D image directly to patients or colleagues by email

•360º image of the kidney, offering the opportunity to zoom on the 3D image from every angle

iURO apps are created in consultation with urologists in order to provide a realistic representation of pathologies and therapies. iURO apps are prepared with the aim of enhancing communication and education options. If you are not a healthcare professional, please note that iURO apps support but never substitute the relation with your healthcare professional.

App Management:

•Scientific Director: Carlos Rioja, Hospital Royo Villanova, Zaragoza, Spain

•Scientific Director: Jorge Rioja, Hospital Miguel Servet, Zaragoza, Spain

•Scientific Director: Sanjeev Bandi, Mackay Urology, Mackay Australia

iURO Scientific Advisory Board:

Lithiasis

•Olivier Traxer, University Pierre et Marie Curie Paris, France

•Adrian Joyce, Spire Leeds Hospital in Roundhay, Leeds, Yorkshire, United Kingdom

Benign Prostatic Hyperplasia

•Jean de la Rosette, AMC University Hospital, Amsterdam, The Netherlands

•Matthias Oelke, Hanover Medical School, Hanover, Germany

Pelvic Floor Disorder, Functional and Female Urology

•David Castro, University of La Laguna, Tenerife, Spain

•Dirk De Ridder, Kliniekhoofd Urologie UZ, Leuven, Belgium

Oncology

•Karim Touijer, Memorial Sloan Kettering Cancer Center, New York, USA

•Raul Parra, Memorial Sloan Kettering Cancer Center, New York, USA

•Peter Scardino, Memorial Sloan Kettering Cancer Center, New York, USA

•Pilar Laguna, AMC University Hospital, Amsterdam

•Sharokh Shariat, Weill Medical College of Cornell University, New York, USA

•Theo de Reijke, AMC University Hospital Amsterdam, The Netherlands

•Octavio Castillo Cadiz, Clínica Indisa, Santiago, Chile

•Jaime Landman, University of California Irvine, Los Angeles, USA

Andrology

•Eduard Garcia, University Hospital Clícic de Barcelona, Barcelona, Spain

•Juan Ignacio Martinez Salamanca, University Hospital Puerta de Hierro Majadahonda, Autonomous University of Madrid, Madrid, Spain

•Ignacio Moncada, Hospital La Zarzuela, Madrid, Spain

•David J Ralph, St Peter’s Andrology Centre, London, United Kingdom

•Nelson Bennett, Lahey Hospital and Medical Center, Burlington, USA

•Rados Djinovic, Sava Perovic Foundation, Belgrade, Serbia